Screening breast MR imaging in women with a history of lobular carcinoma in situ

Radiology

Volumn 261, Issue 2, 2011, Pages 414-420

  Sung, Janice S ^a   Malak, Sharp F ^a   Bajaj, Punam ^a   Alis, Rebecca ^c   Dershaw, D David ^a   Morris, Elizabeth A ^b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b Apollo Clinic and Cradle Hospital ^*  (India)

^c MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANAMNESIS; ARTICLE; BREAST BIOPSY; BREAST CANCER; CANCER DIAGNOSIS; CANCER SCREENING; CARCINOMA IN SITU; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; INTRADUCTAL CARCINOMA; INVASIVE CARCINOMA; LOBULAR CARCINOMA IN SITU; MAJOR CLINICAL STUDY; MAMMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SENSITIVITY ANALYSIS;

ADULT; AGED; BIOPSY; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, LOBULAR; CHI-SQUARE DISTRIBUTION; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HUMANS; INCIDENCE; MAGNETIC RESONANCE IMAGING; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 80054778306     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.11110091     Document Type: Article

References (28)

1. Morris EA, Liberman L, Ballon DJ, et al. MRI of occult breast carcinoma in a high-risk population. AJR Am J Roentgenol 2003;181(3):619-626. (Pubitemid 37021827)
2. Armstrong K, Eisen A, Weber B. Assessing the risk of breast cancer. N Engl J Med 2000;342(8):564-571. (Pubitemid 30117898)
3. Dershaw DD. Mammographic screening of the high-risk woman. Am J Surg 2000;180(4):288-289.
4. Simpson PT, Gale T, Fulford LG, Reis-Filho JS, Lakhani SR. The diagnosis and management of pre-invasive breast disease: pathology of atypical lobular hyperplasia and lobular carcinoma in situ. Breast Cancer Res 2003;5(5):258-262. (Pubitemid 37080856)
5. Arpino G, Laucirica R, Elledge RM. Premalignant and in situ breast disease: biology and clinical implications. Ann Intern Med 2005;143(6):446-457. (Pubitemid 41338942)
6. Li CI, Malone KE, Saltzman BS, Daling JR. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001. Cancer 2006;106(10):2104-2112. (Pubitemid 43673230)
7. Rosen PP, Kosloff C, Lieberman PH, Adair F, Braun DW Jr. Lobular carcinoma in situ of the breast: detailed analysis of 99 patients with average follow-up of 24 years. Am J Surg Pathol 1978;2(3):225-251. (Pubitemid 9093683)
8. Bluemke DA, Gatsonis CA, Chen MH, et al. Magnetic resonance imaging of the breast prior to biopsy. JAMA 2004;292(22):2735-2742. (Pubitemid 39628252)
9. Kuhl CK, Schrading S, Leutner CC, et al. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol 2005;23(33):8469-8476.
10. Orel SG, Schnall MD. MR imaging of the breast for the detection, diagnosis, and staging of breast cancer. Radiology 2001;220(1):13-30. (Pubitemid 32577955)
11. Lee CH, Dershaw DD, Kopans D, et al. Breast cancer screening with imaging: recommendations from the Society of Breast Imaging and the ACR on the use of mammography, breast MRI, breast ultrasound, and other technologies for the detection of clinically occult breast cancer. J Am Coll Radiol 2010;7(1):18-27.
12. Saslow D, Boetes C, Burke W, et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 2007;57(2):75-89. (Pubitemid 46535708)
13. Port ER, Park A, Borgen PI, Morris E, Montgomery LL. Results of MRI screening for breast cancer in high-risk patients with LCIS and atypical hyperplasia. Ann Surg Oncol 2007;14(3):1051-1057.
14. D'Orsi CJ, Bassett LW, Berg WA, et al. Breast Imaging Reporting and Data System: ACR BI-RADS-Mammography. 4th ed. Reston, Va: American College of Radiology, 2003.
15. Clopper C, Pearson ES. The use of confidence or fiducial limits illustrated in the case of the binomial. Biometrika 1934;26(4):404-413.
16. McNemar Q. Note on the sampling error of the difference between correlated proportions or percentages. Psychometrika 1947;12(2):153-157.
17. Obuchowski NA. Nonparametric analysis of clustered ROC curve data. Biometrics 1997;53(2):567-578. (Pubitemid 27262219)
18. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999;94(446):496-509.
19. Gray RJ. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 1988;16(3):1141-1154.
20. Hellquist BN, Duffy SW, Abdsaleh S, et al. Effectiveness of population-based service screening with mammography for women ages 40 to 49 years: evaluation of the Swedish Mammography Screening in Young Women (SCRY) cohort. Cancer 2011;117(4):714-722.
21. Lehman CD. Role of MRI in screening women at high risk for breast cancer. J Magn Reson Imaging 2006;24(5):964-970. (Pubitemid 44658231)
22. Kriege M, Brekelmans CT, Boetes C, et al. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 2004;351(5):427-437.
23. Kuhl CK, Schmutzler RK, Leutner CC, et al. Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: preliminary results. Radiology 2000;215(1):267-279. (Pubitemid 30190541)
24. Warner E, Plewes DB, Shumak RS, et al. Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancer. J Clin Oncol 2001;19(15):3524-3531. (Pubitemid 32730090)
25. Page DL, Kidd TE Jr, Dupont WD, Simpson JF, Rogers LW. Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease. Hum Pathol 1991;22(12):1232-1239.
26. Warner E, Plewes DB, Hill KA, et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 2004;292(11):1317-1325. (Pubitemid 39223222)
27. Warner E, Messersmith H, Causer P, Eisen A, Shumak R, Plewes D. Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer. Ann Intern Med 2008;148(9):671-679. (Pubitemid 351669112)
28. Plevritis SK, Kurian AW, Sigal BM, et al. Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging. JAMA 2006;295(20):2374-2384. (Pubitemid 43788105)